Purpose. To conduct a systematic review of the literature to assess outcomes data on complications associated with implant-based breast reconstruction performed before or after chest wall radiation to assist in guiding the decisionmaking process for reconstruction of the irradiated breast. Methods. Studies from a PubMed search that met predetermined inclusion criteria were identified and included. Complications of interest were low-and high-grade capsular contractures, minor and major complications, reconstruction failure rates, and reconstruction completion rates. Pooled complication rates were calculated. Results. A total of 26 articles were included in the study after screening 1,006 publications, with 14 studies presenting data on prereconstruction radiation and 23 studies presenting data on postreconstruction radiation. Complication rates evaluated in patients exposed to radiation before or after implant reconstruction were not significantly different. Reconstruction failure rates were similar at 19 and 20 % for pre-and postreconstruction radiation patients, respectively. Completion rates were similar at 83 and 80 % for pre-and postreconstruction radiation patients, respectively. Conclusions. Review of the current literature suggests similar overall success and failure rates with radiotherapy provided both before and after reconstruction. Failure rates in both groups of patients are clinically significant when considering implant reconstruction in the setting of radiation.
Implant-based breast reconstruction continues to be the leading form of breast reconstruction in the United States. The American Society of Plastic Surgeons reports over 76,000 implant-based breast reconstruction procedures in 2011 comprising approximately 79 % of all breast reconstruction procedures. 1 Its popularity among surgeons stems from the relative ease of the procedure and the limited time/resource requirements for implantation.
Increasing numbers of breast cancer patients require postmastectomy radiotherapy as part of their cancer treatment. The effectiveness of implant-based breast reconstruction in the setting of radiotherapy has been called into question. 2, 3 Published data on the outcomes of implant reconstruction of the irradiated breast have been inconclusive and contradictory. 4, 5 Nevertheless some authors endorse implant reconstruction procedures in this setting by citing acceptable cosmetic results and patient satisfaction. 6 Postoperative complication rates after implant-based breast reconstruction are known to be higher in irradiated breasts compared to similar nonirradiated breasts. Irradiated breasts, however, are not entirely uniform as the time of delivery of radiation to the breast relative to the time of reconstruction varies. Patients who require radiotherapy either undergo radiotherapy before reconstruction or after reconstruction has been initiated or completed. There is little to no conclusive evidence from clinical trials presenting outcomes on implant reconstruction with these variations in the times of radiotherapy exposure relative to reconstruction.
The aim of this study was to perform a critical appraisal of the available literature to evaluate complication data on implant-based breast reconstruction before and after chest wall radiation to help guide the decision-making process for reconstruction of the irradiated breast.
PATIENTS AND METHODS

Search Criteria
A thorough literature search was conducted using PubMed/Medline in August 2012 to identify all citations reporting outcomes of implant-based breast reconstruction in the setting of radiotherapy. The search terms used were ''immediate versus delayed breast reconstruction,'' ''breast reconstruction and radiation,'' and ''delayed breast reconstruction and radiation.'' These broad search terms were used with the goal of identifying as many studies on the subject as possible before focusing on studies with implantbased reconstruction. Multiple authors independently examined the titles and abstracts of citations and generated a list of articles for review. The studies were then assessed against predetermined inclusion and exclusion criteria (Table 1) .
Data Abstraction
The data were extracted from studies satisfying the inclusion criteria and verified by multiple authors. Any disagreements were resolved by consensus. Variables extracted included study design, patient demographics, method and timing of reconstruction relative to radiotherapy, mean follow-up time, and complication rates.
Capsular contracture was defined as mild (grades IA, B, and II) or severe (grades III and IV). 7 Similar to published complication categories by Hirsch et al. 8 we defined minor complications as complications managed without surgical intervention and major complications as complications requiring surgical intervention. Minor complication categories included grades I and II capsular contractures, seromas, potential infections treated with oral antibiotics, minor wound healing abnormalities, and minor mastectomy flap necrosis that heal spontaneously. Major complication categories included threatened implant exposure, wound dehiscence, loss of implant as a result of exposure, mastectomy skin loss, capsular contracture grades III and IV, hematoma, pain/tightness, injection port migration, deflation, and infection leading to loss of implant. Complications were reported per breast reconstruction, with one breast reconstruction comprising two operations in staged reconstructions using an initial tissue expander. Because each operation on a breast had the potential for complications, multiple complications could be recorded per breast. Reconstructions were considered failures if implants had to be taken out, replaced with flaps, or revised with the addition of a flap. Reconstructions were considered successful and complete in patients who had an implant alone in place at the end of the follow-up period for each study.
Analyses
Our outcomes of interest included minor and major complication rates, rates of capsular contracture, flap failure, and completion rates. It was not possible to conduct a meta-analysis model of these studies because outcomes of interest were not reported with a uniform standard and because there was significant heterogeneity among studies in terms of design and patient characteristics. Furthermore, most of the studies in the review were case series and not comparative studies between prereconstruction and postreconstruction irradiated breasts. From extracted frequencies of the outcomes of interest and the number of breasts for each outcome, we report the rates and 95 % confidence interval for each possible complication or completion rate using the variance-stabilizing FreemanTukey double arcsine transformation method. Overall estimates and 95 % confidence intervals of each outcome of interest were pooled for studies according to whether reconstruction was performed before or after radiation by a random effects meta-analysis of the Freeman-Tukey transformed proportions (Table 2) . Variance between studies was estimated by the DerSimonian-Laird estimator with Chi-square tests of heterogeneity for all outcomes of interest, supplemented by the descriptive measure of I 2 . I 2 is often used as a descriptive measure to represent the proportion of total variation in the estimates of treatment effects that is due to heterogeneity (difference between Studies with no relevant extractable outcomes Studies not published in English studies) rather than to chance. To explore comparisons between prereconstruction and postreconstruction radiotherapy, we report the overall point estimates of each complication rate with confidence intervals, even with significant heterogeneity. All quantitative analysis was performed in R with the meta and rmeta packages.
RESULTS
Study Retrieval and Characteristics
A total of 1,006 citations were identified from our initial PubMed search (Fig. 1) . The application of predetermined inclusion and exclusion criteria resulted in 26 selected articles to be utilized for the study. A summary of study characteristics is included in Table 3 .
Patient Characteristics
Patients included in this study were all treated with mastectomies for breast cancer. Prereconstruction radiotherapy was delivered before reconstruction predominantly for breast-conservation therapy. Postreconstruction radiotherapy was delivered either after placement of tissue expanders or after implant placement.
Capsular Contracture
Ten of the included studies reported on mild capsular contracture. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Rates ranged from 2 to 83 %. 14, 17 The pooled mild capsular contracture rate was 30 % (95 % confidence interval [CI] 0-77) in 98 breasts irradiated before reconstruction, versus 37 % (95 % CI 20-55) in 672 breasts irradiated after reconstruction. Eleven studies reported on severe capsular contracture. [9] [10] [11] [12] 14, [16] [17] [18] [19] [20] [21] Values ranged from 13 to 67 %. 9, 21 The pooled severe capsular contracture rate was 25 % (95 % CI 10-45) in 68 breasts irradiated before reconstruction and 32 % (95 % CI 20-46) in 818 breasts irradiated after reconstruction.
Minor Complications
Seven studies reported data on complications classified as minor. 8, 9, 11, 13, 15, 17, 21 Rates ranged from 0 to 47 %. 13, 15 The pooled rate of minor complications was 18 % (95 % CI 5-36) in 150 breasts irradiated before reconstruction, versus 31 % (95 % CI 17-46) in 246 breasts irradiated after reconstruction.
Major Complications
Sixteen studies reported data on complications classified as major. 8, 9, 13, [15] [16] [17] 19, [21] [22] [23] [24] [25] [26] [27] [28] Rates ranged from 2 to 94 %. 9, 15 The pooled rate of major complications was 49 % (95 % CI 25-72) in 252 breasts irradiated before reconstruction, versus 39 % (95 % CI 24-55) in 708 breasts exposed to radiation after reconstruction.
Failure of Reconstruction/Need for Flap
Nineteen studies reported data on failed attempts at implant-based reconstruction and the need for flaps in addition to or as replacements of previously placed implants. [8] [9] [10] [11] [12] [13] [15] [16] [17] [19] [20] [21] 23, 24, [29] [30] [31] [32] [33] Values ranged from 2 to 45 %. 15, 30 The pooled rate of implant reconstruction failure and need for flaps was 19 % (95 % CI 10-29) in 377 breasts exposed to prereconstruction radiation, versus 20 % (95 % CI 15-25) in 977 breasts exposed to radiation after CI confidence interval, XRT radiotherapy, CC capsular contracture reconstruction. Figure 2 depicts the variability in failure rates among studies; however, the pooled estimate and confidence intervals are similar for failure rates regardless of the timing of radiotherapy to reconstruction.
Completion of Implant-Based Reconstruction
Eight studies reported data on the number of reconstructions that were successfully completed with implants as was initially intended. [8] [9] [10] 15, 16, 20, 29, 33 Values ranged 59-97 %. 8, 15 The pooled rate of successful implant reconstruction was 83 % (95 % CI 68-94) in 311 breasts exposed to prereconstruction radiation, versus 80 % (95 % CI 68-90) in 321 breasts with postreconstruction radiation.
DISCUSSION
The utilization of implant reconstruction in mastectomy patients appears to be on the rise. A recent study by Albornoz et al. 34 querying the Nationwide Inpatient Sample from 1998 to 2008, reported an average increase of 11 % per year of immediate implant-based reconstruction, with a widening gap of this technique relative to autologous forms of reconstruction over time. Possible reasons suggested for this increase include a growing population of younger patients who require mastectomies and lack sufficient adiposity for autologous reconstruction, in addition to a possible cultural shift in breast aesthetics with a preference for a non-ptotic-appearing breast. Another reason is a possible increasing acceptance of silicone implants since its reapproval by the U.S. Food and Drug Administration for general use in 2006. Unfortunately, the registry did not permit an assessment of implant reconstruction rates in the setting of radiotherapy or in a delayed fashion.
The more thorough studies investigating the effect of the relative time of exposure to radiotherapy on outcomes of implant reconstruction were included in this review in an attempt to get a better grasp of the impact of radiation timing on implant-based breast reconstruction. In 2012, Spear et al. 9 looked at postoperative outcomes in two-stage implant reconstructions with use of AlloDerm (Lifecell, Branchburg, NJ) in 73 patients exposed to radiotherapy before or after beginning the reconstruction process. Postreconstruction irradiated patients were found to have higher rates of reconstruction failure (21.4 vs. 11.8 %) and a need for flaps in addition to the implant or as a replacement (16.1 vs. 5.9 %) compared to prereconstruction irradiated patients. Even higher rates of reconstruction failure in prereconstruction irradiated patients were reported by Hirsch et al. 8 In their retrospective review of outcomes in patients exposed to prereconstruction radiotherapy, major complications requiring implant removal or conversion to flaps occurred in as many as 39 % of patients. Although most would agree that failure rates with implant reconstruction in the setting of any form of radiotherapy are higher compared to reconstruction without radiation, there is a significant discrepancy in the actual rates of complications reported even in more recent studies. A few possible explanations for these discrepancies include surgical technique differences from institution to institution, differences in the delivery of radiotherapy, and the limited subset of patients undergoing radiotherapy in one form or another as part of their oncologic treatment.
Complications in this review were categorized as minor or major on the basis of whether or not the specific complication resulted in surgical interventions or failure of reconstruction. Complications were grouped so as to provide a better understanding of the significance of the types of complications encountered with implant reconstruction of the irradiated breast. The need to return to the operating room typically represents a complication of severity that could potentially lead to a failed reconstruction. No significant differences were found in major and minor complications between the study groups, with some overlap of confidence intervals of pooled estimates (Table 2) . Pooled major complications in patients exposed to prereconstruction radiation was 49 % (CI 0.25-0.72) and 39 % (CI 0.24-0.55) in patients exposed to radiation after reconstruction. A possible explanation for this observation in major complication rates may be attributed to the fact that prereconstruction radiation patients are exposed to a greater number of operations after radiation with greater risk for additional injury to already compromised skin. With postreconstruction radiation, the skin is allowed some time to recover from the initial insults of a mastectomy and implant placement before undergoing radiotherapy.
Capsular contractures are one of the more common complications encountered with implant reconstruction, and higher grades are a primary reason for additional operations in the long term. The true etiology of capsular contracture is unclear, but it is ubiquitous to all forms of mammary implant use. Radiotherapy, however, has been demonstrated to result in higher rates of capsular contracture in implant-based breast reconstruction.
14,32 An independent evaluation of capsular contracture was performed, given its common occurrence and potential impact on the overall outcome of reconstruction. Here also, not all contractures are clinically significant, as most surgeons would not operate on low-grade (mild) contractures. Pooled mild and severe capsular contracture rates were not significantly different in patients exposed to postreconstruction radiotherapy relative to patients irradiated before beginning reconstruction. Although differences between the groups were not significant, the pooled rates of contractures in both study groups (25 and 32 %) indicate that even in the absence of other complications, one in three to four patients may have a contracture severe enough to warrant an operation. This information would be helpful to patients who might be considering implant reconstruction when radiotherapy is anticipated.
The ultimate success rates of implant reconstruction in the setting of radiotherapy delivered before or after reconstruction is important because it provides additional information on the feasibility of this reconstructive option. Pooled data from our analysis revealed similar rates of reconstruction failure or the need for flaps in patients exposed to radiation before (19 %) or after the initiation of breast reconstruction (20 %). Reconstruction completion rates for prereconstruction and postreconstruction irradiated breasts were 83 and 80 %, respectively, which are in agreement with the pooled failure rates. These failure rates are lower than those noted in early individual reports, likely reflecting changes attributable to evolving surgical techniques and changes in radiation delivery. 32 One major change in surgical technique over the past few years is the widespread use of acellular dermal matrices for partial coverage of implants. Of note, however, a recent singlecenter retrospective comparison of acellular dermal matrix use to submuscular implant coverage in the setting of radiation found no difference in the complication rates associated with these techniques. 35 This study has a number of limitations. Most importantly, the results found are limited by the strength of the available evidence in the literature. Heterogeneity between included studies was significant, likely as a result of clinical and methodological differences between studies. Additionally, there was an absence of randomized controlled trials exploring this important question. There were fewer published studies in the literature that presented data on patients exposed to prereconstruction radiotherapy, likely because a good number of surgeons opt for autologous reconstruction in this setting. Outcomes reported by individual studies were also not uniform precluding rigorous statistical analysis. We were, however, able to shed light on patterns in complication rates and bring the need for prospective trials studying the role of implant reconstruction in the setting radiotherapy to the attention of physicians and researchers.
In conclusion, radiotherapy, although a critical component of breast cancer therapy, is associated with higher rates of implant-based reconstruction complications relative to similar reconstructive techniques in the absence of radiation. 9 In this analysis to determine complication rates and potential differences in implant reconstruction outcomes as a result of variations in the time of exposure to radiation, we found similar overall success and failure rates; failure rates were clinically significant in both groups. Although technically feasible, implant-based reconstruction in the setting of radiotherapy is associated with relatively high rates of complications. Patients should be counseled appropriately on these potential complications so they may make fully informed decisions.
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